Brilliant Blue G eye compound recalled due to fungal infection

Posted on

A voluntary recall has been issued by Franck’s Compounding Lab for its Brilliant Blue G eye compound, due to reports of fungal eye infections in patients. The following lot numbers of Brilliant Blue G have been linked with contamination: 08232011@80, 10132011@6, 10112011@82, 10192011@125.

The Food and Drug Administration has received multiple complaints of fungal endophthalmitis appearing in patients treated with Brilliant Blue G during eye surgery. Brilliant Blue G has not been approved for medical use in the United States by the FDA. The FDA requests all physicians report any infections associated with use of the Brilliant Blue G compound to the administration’s MedWatch Safety Information and Adverse Event Reporting Program. The product is currently under investigation by the FDA as well as the Centers for Disease Control and local and state public health agencies.

The company is currently recalling all lots of Brilliant Blue G, including but not limited to those listed above. Physicians who have purchased Brilliant Blue G are encouraged to return all lots of the product, including any unused portions, to Frank’s Compounding. Upon receipt of the items, the company will credit the physicians with a full refund.

As a Long Beach personal injury lawyer, I fully realize the harm that can be done by defective medical products. If you or someone you love has been negatively affected by a recalled product, please consider contacting a Riverside personal injury lawyer.